Novogen believes that the technology that it is developing offers the hope of finally being able to reverse and to prevent the disease processes underlying the most common degenerative diseases in our community.

What does this mean to the patient?

For most patients with major disorders such as cancer, heart disease, inflammatory bowel disease, and other chronic inflammatory diseases, the best therapeutic options available currently are drugs that at best might slow down the rate of progression of the disease, or at the least might alleviate the symptoms without really changing the underlying disease process.

Novogen believes that its technology platform represents a major step forward for patients with these diseases, bringing hope of being able to block or to remove the underlying disease process so that the disease is fully controlled. Importantly, it is intended to deliver this outcome in a safe, well-tolerated manner that does not harm normal, unaffected tissues.

In this section you can learn more about the technology that underlies this optimism, about the process that drugs undergo in order to bring them to market (drug development), and about the specific drugs that are in the Novogen pipeline.